Viatris Inc. - Common Stock (NQ:VTRS)

17.73 +0.13 (+0.74%)

Delayed Quote Updated: 3:18 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market ↗

October 16, 2025

Via The Motley Fool

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs ↗

October 09, 2025

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns.

Via Benzinga

Topics Government World Trade

3 Cash-Producing Stocks We Keep Off Our Radar

October 01, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

3 Mid-Cap Stocks We Keep Off Our Radar

September 16, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Explore the top gainers and losers within the S&P500 index in today's session. ↗

September 15, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

3 Value Stocks We Steer Clear Of

September 09, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

1 Unprofitable Stock with Impressive Fundamentals and 2 That Underwhelm

September 08, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

1 Volatile Stock on Our Buy List and 2 Facing Challenges

September 04, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

September 02, 2025

Are the Dow's biggest yields a bargain or a warning sign? Here's how the top payouts stack up, and what that could mean for income investors.

Via The Motley Fool

Topics Stocks

US-India Trade War Escalates: New Tariffs Spark Inflation Fears and Corporate Profit Warnings

August 29, 2025

The global trade landscape has once again been rattled as the United States officially implemented sweeping new tariffs on a significant portion of imports from India. Effective August 27, 2025, these...

Via MarketMinute

Topics Economy Government Supply Chain

S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot ↗

August 26, 2025

The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon.

Via Benzinga

Topics Stocks

3 Stocks Under $50 Walking a Fine Line

August 25, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Topics Artificial Intelligence

Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment

August 19, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q2, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Hyped Up Stocks That Fall Short

August 19, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS ↗

August 16, 2025

Greenlight Capital, led by David Einhorn, has disclosed its Q2 2025 13F filing trades.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Thursday. ↗

August 14, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

August 14, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Artificial Intelligence Economy

Missed Opt-Out Deadline Could Cost Investors Millions In Perrigo Fraud Suit ↗

August 13, 2025

Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements.

Via Benzinga

Topics Fraud

VTRS Q2 Deep Dive: Pipeline Progress and Cost Discipline Drive Results Amid Industry Headwinds

August 13, 2025

Medication company Viatris (NASDAQ:VTRS) announced better-than-expected revenue in Q2 CY2025, but sales fell by 5.6% year on year to $3.58 billion. The company expects the full year’s revenue to be...

Via StockStory

Topics World Trade

Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Stocks

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum ↗

August 12, 2025

FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $80-100 million sales and a 2025 launch.

Via Benzinga

Which S&P500 stocks are moving on Monday? ↗

August 11, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Why Viatris (VTRS) Stock Is Up Today

August 11, 2025

Shares of medication company Viatris (NASDAQ:VTRS) jumped 3% in the morning session after it received approval from the U.S. Food and Drug Administration (FDA) for its Iron Sucrose Injection, USP, the...

Via StockStory

Stay informed with the top movers within the S&P500 index on Thursday. ↗

August 07, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Viatris (NASDAQ:VTRS) Beats Q2 Sales Targets, Stock Soars

August 07, 2025

Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 5.6% year on year to $3.58 billion. The company expects the full year’s...

Via StockStory

Viatris (VTRS) Reports Earnings Tomorrow: What To Expect

August 05, 2025

Medication company Viatris (NASDAQ:VTRS) will be reporting earnings this Thursday before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Judge Rules Mylan Did Not Infringe Novo Nordisk Patent In Wegovy Generic Case ↗

July 25, 2025

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, contributory, and induced infringement claims.

Via Benzinga

Topics Intellectual Property

1 Mid-Cap Stock on Our Buy List and 2 We Avoid

July 23, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.